SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is actively trending ahead of its earnings report, sparking a widespread debate among investors on whether it will follow the recent "sell the news" pattern seen with other AI chip stocks, or if its robust custom silicon and AI networking demand will drive a rally. The community is closely watching its AI revenue growth and guidance, with some optimistic about its core business in data center infrastructure and others concerned about broader market sentiment and hyperscaler spending trends.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending ahead of its Q4 earnings report, with community sentiment largely negative due to sustained underperformance and price declines, even as some investors highlight its low valuation, substantial cash reserves, and strategic competitive advantages within the Chinese e-commerce sector.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending amidst fervent buyout speculation, fueled by recent volume spikes and rumors of potential acquisition by suitors such as Jazz Pharmaceuticals or Ipsen. The community is actively debating a potential takeover, with many believing the company's strong oncology pipeline, including OJEMDA and the Mersana acquisition, and current valuation make it an attractive target in an active M&A market.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending after securing a $2.4 billion contract to build a 1.2-gigawatt natural gas plant for Applied Digital's AI data centers, a deal widely regarded as transformational given its magnitude relative to the company's market capitalization. The community is actively discussing BW's strong position to rapidly deliver critical power solutions for the booming AI infrastructure, with potential for further substantial projects.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is experiencing significant momentum driven by a slew of new mobile network operator partnerships, including Telus becoming an equity shareholder, alongside strong analyst upgrades and solid revenue performance. The community is buzzing with short squeeze potential and high future valuation expectations for its direct-to-device satellite technology, especially given its strong relative strength in the current market.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging as a substantial patent settlement removes a major legal overhang, while the FDA's reversal to review its flu vaccine application is driving bullish sentiment and sparking community talk of a massive short squeeze, with attention now turning to its promising oncology pipeline.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is highly volatile amid geopolitical concerns that triggered market circuit breakers; however, robust underlying demand for AI-driven memory chips from major holdings like Samsung and SK Hynix is fueling a strong rebound, leading community discussion on whether initial market fear was overblown.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic (LUNC) is trending due to Binance's recent token burn, which is fueling community optimism about supply reduction and a potential price surge. This comes as the market also processes Do Kwon's sentencing, sparking debate among investors regarding its varied long-term implications for LUNC's recovery and ongoing ecosystem developments.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini's new prediction market is live, supported by its CFTC Designated Contract Market (DCM) license, sparking community excitement as it enters this competitive sector. High short interest and rising borrow rates are simultaneously fueling short squeeze speculation.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is navigating market volatility following its recent earnings beat and raised guidance, which was initially met with skepticism over AI disruption fears but was bolstered by a newly authorized share buyback program. The community is sharply divided between frustration over perceived price manipulation and strong conviction in the company's long-term opportunity in securing AI agents, despite broader sector concerns about new AI tools.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The reverse split would reduce the number of outstanding shares from about 18.3 million to around 1.5 million.</li><li>This marks the company’s second reverse stock split since March 2024, when it carried out a 1-for-7 consolidation.</li><li>Lifeward’s board also approved increasing the authorized share capital to 100 million shares.</li></ul>Shares of Lifeward (LFWD) slumped nearly 20% to their all-time low after the company announced it would implement a 1-for-12 reverse stock split effective Feb. 24, 2026.<a href="https://stocktwits.com/symbol/LFWD">LFWD</a> stock will begin trading on a post-split basis the same day under the existing ticker symbol. The move is aimed at boosting the share price to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.<h2 class="st-heading-2">Outstanding Shares To Be Reduced To Around 1.5 Million</h2>The move follows shareholder approval in January, which authorized the board to determine whether to implement a reverse split of the company’s outstanding ordinary shares and, if so, to set the ratio within a range of 1-for-2 to 1-for-12, giving the board full discretion over the outcome.Under the reverse split, every 12 ordinary shares will automatically convert into one share, reducing outstanding shares from about 18.3 million to around 1.5 million. The board also approved increasing the authorized share capital to 100 million shares.This marks the company’s second reverse split in nearly two years. In March 2024, Lifeward completed a 1-for-7 reverse split of its ordinary shares, reducing the number of outstanding shares from around 60.1 million to about 8.6 million.<h2 class="st-heading-2">Partnership With Oramed For Protein Oral Delivery Technology</h2>In January, Lifeward partnered with Oramed Pharmaceuticals (ORMP) to integrate Oramed’s proprietary POD protein oral delivery technology into its platform.Under the terms of the deal, Oramed could acquire up to a 49.99% equity stake in Lifeward. The investment structure is expected to provide Lifeward with access to up to $47 million in capital through a combination of equity, convertible notes, milestone-based funding, and warrant coverage, supporting future growth initiatives.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Meanwhile, retail sentiment on Stocktwits remained in the ‘neutral’ zone over the past 24 hours.Year-to-date, the stock has declined around 25%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/spai-stock-reverses-gains-safe-pro-us-government-ai-contract/cZRN7XMR4x0">This AI-Based Defense Company Secured A US Government Contract – So, Why Did The Stock Reverse Pre-Market Gains?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years

The company announced it would implement a 1-for-12 reverse stock split effective Feb. 24, 2026.

Equity

Oramed and Lifeward Announce Strategic Transaction

Oramed and Lifeward Announce Strategic Transaction Oramed and Lifeward Announce Strategic Transaction PR Newswire NEW YORK, Jan. 13, 2026 Transaction Will TransferOramed's Oral Drug Delivery Platform...

Lifeward Achieves European Approval for Latest ReWalk Exoskeleton

LFWD secures CE mark for its ReWalk 7 Personal Exoskeleton, unlocking new European sales potential with advanced features.

Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates

Lifeward (LFWD) delivered earnings and revenue surprises of -132.00% and -11.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Rigetti Computing, Inc. (RGTI) Reports Q2 Loss, Misses Revenue Estimates

Rigetti Computing (RGTI) delivered earnings and revenue surprises of +16.67% and -5.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates

Turtle Beach (TBCH) delivered earnings and revenue surprises of +48.15% and -0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Verb Technology Company, Inc. (VERB) Reports Q2 Loss, Tops Revenue Estimates

Verb Technology (VERB) delivered earnings and revenue surprises of +12.25% and +51.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

8x8 (EGHT) Q1 Earnings Match Estimates

8x8 (EGHT) delivered earnings and revenue surprises of 0.00% and +2.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Nasdaq-listed shares of medical technology company Lifeward (LFWD) fell by about 2% on Monday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.rewalk.com/news-releases/news-release-details/lifeward-names-mark-grant-new-ceo">announced</a> that Mark Grant was appointed its new President and CEO.The new appointment will be effective June 2, and Grant will replace Larry Jasinski. To help with the transition, Jasinski will serve as co-CEO and in an advisory capacity until June.Lifeward said he will continue in an advisory capacity on an as-needed basis until the end of 2025.Grant previously worked with Bristol Myers Squibb, FLA Orthopedics, and health tech company Medtronic.Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training.The company said that the Board of Directors has approved an inducement award of 400,000 options to purchase ordinary shares of Lifeward for Grant.The award will be made on the date he joins the company and vests in four equal annual installments beginning on the first anniversary of the new CEO’s joining date, subject to his continued employment with the company.Lifeward designs, develops, and commercializes solutions for individuals with physical limitations or disabilities, including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.The company recently launched the ReWalk 7, the newest generation of personal exoskeleton, in the U.S. market following FDA clearance in March.Earlier this month, Lifeward reported an adjusted net loss of $4.6 million, or $0.44 per share, in the first quarter of 2025, compared to a loss of $5.3 million, or $0.62 per share, during the first quarter of 2024. The company’s revenue for the three months through the end of March was $5 million.On Stocktwits, retail sentiment around Lifeward fell from ‘bearish’ to ‘extremely bearish’ territory over the past 24 hours while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:629/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_19_at_1_07_25_PM_png_38ed886908.webp" alt="LFWD's Sentiment Meter and Message Volume as of 1:05 p.m. ET on May 19, 2025 | Source: Stocktwits" width="629" height="61"><figcaption>LFWD's Sentiment Meter and Message Volume as of 1:05 p.m. ET on May 19, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/LFWD">LFWD stock</a> is down by 43% this year and over 74% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/netflix-stock-edges-lower-after-jp-morgan-downgrade-despite-higher-price-target/ch0cubqRb82">Netflix Stock Edges Lower After JPMorgan Downgrade Despite Higher Price Target</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Lifeward Appoints Mark Grant As New CEO: Retail Sentiment Dips

Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training. 

Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

Current Price	$6.00
Prev Close	$6.40
Open	$6.38
Dividend Yield	0.00%
50-Day Moving Average	$7.18
Beta	1.28
Avg. Volume	32,667.40
PE Ratio	-0.18

52-Week High	$35.40
52-Week Low	$4.14
Market Capitalization	$13.43M
EPS (Annual)	-$39.96
Price to Book	0.71
Revenue Per Employee	$320,787.50

LFWD
Rewalk Robotics Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LFWD News

LFWDRewalk Robotics Ltd.